Biogen appoints Sean Godbout as Chief Accounting Officer effective March 1, 2025

BIOGEN INC.

Sean Godbout to succeed Robin Kramer as CAO and principal accounting officer; Kramer transitions to CFO role upon McDonnell's retirement.
Michael McDonnell to retire as CFO on March 1, 2025; Kramer previously announced as successor.
Godbout, age 50, internal promotion from Global Corporate Controller (since Oct 2023), joined Biogen in 2007.
Base salary $400,000; annual bonus target 40% of base; eligible for long-term incentive grants and executive severance plan.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Robin Kramer

Chief Financial Officer

BIIB · BIOGEN INC.

Effective: 2025-03-01
Successor: Michael McDonnell
Filed: January 15, 2025, 6:59 PM ET

As previously announced, Ms. Kramer has been appointed the Company’s Chief Financial Officer, effective upon the retirement of Michael McDonnell, the Company’s current Chief Financial Officer.

Appointed

Sean Godbout

Chief Accounting Officer

BIIB · BIOGEN INC.

Effective: 2025-03-01
Successor: Robin Kramer
Filed: January 15, 2025, 6:59 PM ET

On January 13, 2025, Biogen Inc. (the “Company”) appointed Sean Godbout as Vice President, Chief Accounting Officer & Global Corporate Controller and designated Mr. Godbout as the Company’s principal accounting officer, in each case effective as of March 1, 2025.

Departed

Michael McDonnell

Chief Financial Officer

BIIB · BIOGEN INC.

Effective: 2025-03-01
Successor: Robin Kramer
Filed: January 15, 2025, 6:59 PM ET

Mr. McDonnell will retire on March 1, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robin Kramer was appointed as Chief Financial Officer at BIOGEN INC..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

As previously announced, Ms. Kramer has been appointed the Company’s Chief Financial Officer, effective upon the retirement of Michael McDonnell, the Company’s current Chief Financial Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Sean Godbout was appointed as Chief Accounting Officer at BIOGEN INC..

Action: appointed
Role: Chief Accounting Officer

Exact text from the filing

On January 13, 2025, Biogen Inc. (the “Company”) appointed Sean Godbout as Vice President, Chief Accounting Officer & Global Corporate Controller and designated Mr. Godbout as the Company’s principal accounting officer, in each case effective as of March 1, 2025.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael McDonnell departed as Chief Financial Officer at BIOGEN INC..

Action: retire
Role: Chief Financial Officer

Exact text from the filing

Mr. McDonnell will retire on March 1, 2025.

View on SEC.gov

BIOGEN INC. filing history →

Source: SEC EDGAR

accession 0001193125-25-006578

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.